CHM and hepatocellular carcinoma: The finding of CHM efficacy as an adjunctive therapy for breast cancer is similar to the findings of other reviews for hepatocellular carcinoma, non-small-cell lung cancer, colorectal cancer, and nasopharyngeal carcinoma [58, 64–66].